Immunodermatology
Unmatched testing expertise across a broad spectrum of immunodermatology disorders
Fusing an industry-leading portfolio of unique assays with world-class dermatopathology and cutaneous immunodermatology interpretive expertise, Mayo Clinic Laboratories’ immunodermatology testing provides accurate answers on a wide array of challenging immune-mediated skin diseases.
More information
Powering innovation
Basic and translational immunology research conducted at Mayo Clinic consistently provides valuable insights into the biology and function of the immune system. These discoveries propel development of new and unique assays to clarify and refine diagnosis for individuals with allergies, chronic inflammation and other immune-mediated diseases.
Patient-first approach
The unique relationship between our immunodermatology laboratory and Mayo Clinic’s nationally recognized dermatopathology and immunodermatology clinical practices supports development of patient-focused tests that address the most serious and complex autoimmune skin cases.
Unmatched expertise
A cross-disciplinary team of immunodermatology experts, clinicians, and laboratory scientists provide an unparalleled standard of laboratory care for immuno-dermatologic conditions. These nationally renowned dermatopathology specialists are involved in interactive research that pushes the boundaries of what is known about these rare conditions. Our experts are available to consult on tests ordering, results, and next steps.
Acantholytic autoimmuneblistering disease classification
Key testing
- CIB | Cutaneous Direct Immunofluorescence Assay, Varies
- CIFA | Cutaneous Immunofluorescence Antibodies, IgA, Serum
- CIFS | Cutaneous Immunofluorescence Antibodies, IgG and IgG4, Serum
- DSGAB | Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), IgG Antibodies, Serum
- PNPAB | Paraneoplastic Pemphigus Antibody, IgG, Serum
Blistering, ulcerative, or erosive disease
Key testing
- BPAB | Bullous Pemphigoid, BP180 and BP230, IgG Antibodies, Serum
- CIB | Cutaneous Direct Immunofluorescence Assay, Varies
- CIFA | Cutaneous Immunofluorescence Antibodies, IgA, Serum
- CIFS | Cutaneous Immunofluorescence Antibodies, IgG and IgG4, Serum
- COL7 | Anti-Collagen type VII, IgG Antibodies, Serum
- DSGAB | Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), IgG Antibodies, Serum
- PNPAB | Paraneoplastic Pemphigus Antibody, IgG, Serum
- RSBV | Rare Subepithelial Autoimmune Blistering Disease Variants, Serum
Subepithelial autoimmune blistering disease classification
Key testing
- BPAB | Bullous Pemphigoid, BP180 and BP230, IgG Antibodies, Serum
- CIB | Cutaneous Direct Immunofluorescence Assay, Varies
- CIFA | Cutaneous Immunofluorescence Antibodies, IgA, Serum
- CIFS | Cutaneous Immunofluorescence Antibodies, IgG and IgG4, Serum
- COL7 | Anti-Collagen type VII, IgG Antibodies, Serum
- DSGAB | Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), IgG Antibodies, Serum
- RSBV | Rare Subepithelial Autoimmune Blistering Disease Variants, Serum